Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image
    • - PMLiVE

    Pharmaceutical Market Europe – December 2025

    Thermo Fisher Scientific’s Martin Danielson talks to PME; Celebrating the 2025 PMEAs; Redefining the prostate cancer landscape

    - PMLiVE

    Pharmaceutical Market Europe – November 2025

    ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains

    - PMLiVE

    Pharmaceutical Market Europe – October 2025

    Unravelling the journey on the ‘Patient Metro’; Diagnosing Alzheimer’s takes sensitivity, access and education; Advances in clinical pathway management

    - PMLiVE

    Pharmaceutical Market Europe – September 2025

    Will data and AI transform launch excellence? The impact of us tariffs on healthcare and life sciences; The power of digital and AI engineering

    - PMLiVE

    Pharmaceutical Market Europe – July/August 2025

    Full coverage of this year’s Communiqué Awards; The importance of patient engagement; Cannes Lions 2025 highlights

    - PMLiVE

    Pharmaceutical Market Europe – June 2025

    Communicating with HCPs through AI; ASCO 2025 highlights; The impact of US tariffs on pharma manufacturing

    - PMLiVE

    Pharmaceutical Market Europe – May 2025

    Rising to meet the challenges of clinical trials; Accelerating access to rare disease treatments; Maximising the potential of AI in pharma

    - PMLiVE

    Pharmaceutical Market Europe – April 2025

    How HCPs and patients are partnering to transform care; The impact of MS on ageing patients; AI in healthcare

    - PMLiVE

    Pharmaceutical Market Europe – March 2025

    PMLiVE’s Top Pharma List is live!; Omnichannel – breaking down the barriers; Rare diseases – improving patient access

    - PMLiVE

    Pharmaceutical Market Europe – February 2025

    Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in clinical trials

    - PMLiVE

    Pharmaceutical Market Europe – January 2025

    Avalere Health’s Amar Urhekar on his career path; Insights from ASH 2024; The science behind gene-silencing technology

    - PMLiVE

    Pharmaceutical Market Europe – December 2024

    Sanofi’s John Forni on the escalating challenges of treating COPD; The need for a human touch in an AI world; PMGroup celebrates the 24th PMEAs!